(Q46751641)

English

Aspirin in type 2 diabetes, a randomised controlled study: effect of different doses on inflammation, oxidative stress, insulin resistance and endothelial function

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/24372992

Aspirin in type 2 diabetes, a randomised controlled study: effect of different doses on inflammation, oxidative stress, insulin resistance and endothelial function (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/24372992

type 2 diabetes

0 references

0 references

0 references

1 reference

based on heuristic

inferred from title

insulin resistance

1 reference

based on heuristic

inferred from title

author name string

R P Raghavan

1

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/24372992

D W Laight

2

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/24372992

M H Cummings

3

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/24372992

publication date

22 December 2013

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/24372992

International Journal of Clinical Practice

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/24372992

68

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/24372992

2

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/24372992

271-277

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/24372992

Framingham, SCORE, and DECODE risk equations do not provide reliable cardiovascular risk estimates in type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12310

21 January 2018

Insulin sensitivity in subjects with type 2 diabetes. Relationship to cardiovascular risk factors: the Insulin Resistance Atherosclerosis Study

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12310

21 January 2018

Endothelial activation by angiotensin II through NFkappaB and p38 pathways: Involvement of NFkappaB-inducible kinase (NIK), free oxygen radicals, and selective inhibition by aspirin

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12310

21 January 2018

Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12310

21 January 2018

Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12310

21 January 2018

Prevention of inflammation-induced endothelial dysfunction: a novel vasculo-protective action of aspirin

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12310

21 January 2018

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12310

21 January 2018

Aspirin for primary prevention of cardiovascular events in people with diabetes, etc.

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12310

21 January 2018

The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease.

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12310

21 January 2018

Photoplethysmographic assessment of pulse wave reflection: blunted response to endothelium-dependent beta2-adrenergic vasodilation in type II diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12310

21 January 2018

Use and abuse of HOMA modeling

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12310

21 January 2018

The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12310

21 January 2018

Treadmill exercise in claudicants on aspirin results in improved antioxidant status but only minimal platelet activation

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12310

21 January 2018

Renal effects of aspirin are clearly dose-dependent and are of clinical importance from a dose of 160 mg.

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12310

21 January 2018

Salicylic acid in the serum of subjects not taking aspirin. Comparison of salicylic acid concentrations in the serum of vegetarians, non-vegetarians, and patients taking low dose aspirin

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12310

21 January 2018

Baseline characteristics of participants in the JUPITER trial, a randomized placebo-controlled primary prevention trial of statin therapy among individuals with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12310

21 January 2018

Identifiers

10.1111/IJCP.12310

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/24372992

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/24372992

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46751641&oldid=2129836799"